Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 1999

View Archived Issues

Forest restructures Climara agreement with Berlex

Medeva announces half-year highlights

Early-stage R&D at BioCryst: Q2 highlights

Rochester Medical's female incontinence device receives CE mark

Avant's complement-selectin inhibitor reduces brain damage in mouse model of stroke

Eligix cleared to initiate pivotal trial of DLI purification technology

Kos and Knoll reach definitive agreement for promotion of antihypertensive drugs

Kinetek initiates development of ILK and PKB inhibitors for cancer therapy

Biovail to acquire Fuisz

FDA approves pediatric formulation of Topamax

Heterocyclic compounds as potent and selective NK2 antagonists

Asmarine A and B: novel cytotoxic alkaloids produced by marine organism

Novel epipodophyllotoxin derivatives with excellent antitumor activity

Potassium channel modulators designed at Novo Nordisk especially for endocrine disorders

Dopaminergic agents for schizophrenia and Parkinson's disease from AHP

Warner-Lambert patents new series of dopamine D4 antagonists

International patent recently published covering AstraZeneca PKC inhibitors

Mechanism of gastroprotective effects of lafutidine determined in in vitro and in vivo studies

Postischemic YM-872 investigated for neuroprotective effects in model of acute ischemic stroke

NS-49: preclinical pharmacokinetics of potential new agent for stress incontinence

Shire and Roberts enter definitive merger agreement

Elan and Merck establish second technology transfer and license agreement

Schering-Plough launches Rebetol combination therapy in the U.K.

FDA advisory committee OKs safety and efficacy of Rapamune

FDA approves Relenza for treatment of influenza

Second U.S. patent covers GVAX cancer vaccine technology; positive lung cancer results reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...